Alterity Therapeutics (ATHE) announced that new presentations related to its Multiple System Atrophy program were delivered at the American ...

Alterity Therapeutics Limited, a pharmaceutical company specializing in the development of therapeutic drugs, has announced its compliance with the Takeovers Panel General Guidance Note 20.

In this article, we are going to take a look at where Alterity Therapeutics Limited (NASDAQ:ATHE) stands against other best Australian stocks to buy according to billionaires. In December 2024 ...

MELBOURNE, Australia and SAN FRANCISCO, March 27, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a ...

In this article, we are going to take a look at where Alterity Therapeutics Limited (NASDAQ:ATHE) stands against other best Australian stocks to buy according to billionaires. Australian Market ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

Alterity Therapeutics Phase 2 Data Monitoring ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.